Products
In this classification an abnormal hemoglobin assay is a device consisting of the reagents, apparatus, instrumentation, and controls necessary to isolate and identify abnormal genetically determined hemoglobin types US FDA regulates Abnormal hemoglobin assay under 21 CFR 864.7415 and under FDA product code GKA.
How AGI delivers it
Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
For Abnormal hemoglobin assay, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
Get the professional outcome delivered as software, priced on results, not headcount.
For Abnormal hemoglobin assay, get the professional outcome delivered as software, priced on results, not headcount.
Value flow